Our analysts evaluate clinical trial data, along with information regarding safety issues, coverage policies from the private and public sectors, regulatory approvals, consensus statements, and an overall projection of the potential clinical efficacy and economic impact of the technology. Reports are reviewed annually up to 5 years post publication to determine if there is new literature or evidence that would impact a change in rating and warrant an updated report.
Focus of the Report: The focus of this Health Technology Assessment is to evaluate the effectiveness and safety of repetitive transcranial magnetic stimulation (rTMS) for the treatment of adult patients with bipolar disorder (BD).
Technology Description: Transcranial magnetic stimulati…
Focus of the Report: This Health Technology Assessment focuses on evaluating the effectiveness and safety of the LiverMultiScan compared with other imaging and blood marker tests for assessment of liver fibrosis or steatosis in patients who have known or suspected non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NAS…
Focus of the Report: The focus of this Health Technology Assessment is evaluation of the effectiveness and safety of electrical impedance spectroscopy (EIS) as an adjunct to conventional clinical examination alone or combined with dermoscopy for diagnosis of cutaneous melanoma in patients who have suspicious skin lesions.
read more
Focus of the Report: The focus of this Health Technology Assessment is to evaluate the effectiveness and safety of the minimally invasive lumbar decompression (mild) procedure, an approach that uses a proprietary surgical kit (mild; Vertos Medical Inc.) to treat lumbar spinal stenosis (LSS) in adult (≥ 18 years old) patients.
read more
Focus of the Report: The focus of this Health Technology Assessment (HTA) is to evaluate the effectiveness and safety of theta burst stimulation (TBS), alone and compared with repetitive transcranial magnetic stimulation (rTMS) and/or with sham TBS, for the management of treatment-resistant major depressive disorder (MDD) (unipolar treatment-…
Focus of the Report: The focus of this Health Technology Assessment is evaluation of the effectiveness and safety of the trabecular bone score (TBS) as an adjunct to bone mineral density (BMD) measurement and/or other validated tools incorporating patient information for prediction of fracture risk and guidance of preventive treatment in post…
Focus of the Report: The focus of this Health Technology Assessment (HTA) is to evaluate the effectiveness and safety of cooled radiofrequency ablation (CRFA) and pulsed radiofrequency (PRF) for the treatment of chronic low back pain (CLBP) that originates from the sacroiliac joint (SIJ).
Tec…
Focus of the Report: The focus of this Health Technology Assessment (HTA) is to evaluate the effectiveness and safety of the Mako Robotic-Arm assisted total knee arthroplasty (RATKA) system (Stryker) compared with manual total knee arthroplasty (TKA) for the treatment of knee osteoarthritis (KOA).
read more
Focus of the Report: The focus of this Health Technology Assessment (HTA) is to evaluate the effectiveness and safety of conventional (i.e., continuous, thermal) radiofrequency ablation (RFA) for sacroiliac joint (SIJ) denervation for the treatment of chronic low back pain (CLBP) thought to arise from the SIJ.
Focus of the Report: This Health Technology Assessment (HTA) focuses on high-intensity focused ultrasound (HIFU) for primary treatment of localized prostate cancer (PCa).
Technology Description: HIFU is a minimally invasive treatment that ablates malignant prostatic tissue using high-i…